Target intelligence / Profile preview

Rho guanine nucleotide exchange factor TIAM2 (TIAM2)

Target
TIAM2
Molecular classification
Enzyme, Rho GTPase regulatory protein
01

Overview

TIAM2 (Rho guanine nucleotide exchange factor TIAM2) is a guanine nucleotide exchange factor (GEF) that specifically activates Ras-related C3 botulinum substrate 1 (RAC1), a Rho-like small GTPase, by stimulating the exchange of GDP for GTP and shifting RAC1 to its active, GTP-bound state. TIAM2 functions to modulate cell motility, cytoskeletal reorganization, and directional cell movement, and it plays a role in neural cell development and migration. Alternative splicing produces multiple isoforms with distinct biological effects. TIAM2 and its closely related paralog TIAM1 are involved in cancer cell invasion and metastasis. Disease associations include lymphoma and Griscelli syndrome type 3, and abnormal TIAM2 activity is linked to altered cell motility in cancer and potentially neural development disorders.

Other names
TIAM Rac1 associated GEF 2KIAA2016STEFSIF and TIAM1-like exchange factorT-lymphoma invasion and metastasis-inducing protein 2Sif and Tiam1-like exchange factorTIAM-2rho guanine nucleotide exchange factor TIAM2T cell lymphoma invasion and metastasis 2
02

Mechanism of action

Inhibition of GEF activity (potential, for experimental inhibitors) Modulation of RAC1 activation (by affecting GDP-GTP exchange)

03

Biological functions

Signal transduction (connecting extracellular signals to cytoskeletal activity)Cell motility (including directional cell movement)Cytoskeleton organization (modulates actin dynamics)Neural cell developmentCell migration
04

Disease associations

Cancer (notably invasion and metastasis; especially lymphoma, hepatocellular carcinoma)LymphomaGriscelli syndrome, type 3(Potential) Neurodevelopmental/neurological disorders (based on function in neurons; direct links are stronger for TIAM1, but TIAM2 is implicated via functional similarity)
05

Safety considerations

Off-target inhibition could affect cytoskeletal dynamics and cell motility, raising risk for neurodevelopmental and metastatic side effectsPotential toxicity with overexpression affecting normal neural cell migration and development

Beyond the preview

Go deeper on Rho guanine nucleotide exchange factor TIAM2 (TIAM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho guanine nucleotide exchange factor TIAM2 (TIAM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call